Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice
Niu Shi(Hiroshima University), Kazuaki Chayama(RIKEN Center for Integrative Medical Sciences), C. Nelson Hayes(Hiroshima University), Michio Imamura(Hiroshima University), Eisuke Murakami(Hiroshima University), Masataka Tsuge(Hiroshima University), Hiromi Abe(Hiroshima University), Hiroshi Aikata(Hiroshima Prefectural Hospital), Akihito Okazaki(Shiga Medical Center), Hirotaka Matsui(Hiroshima University), Nobuhiko Hiraga(RIKEN Center for Integrative Medical Sciences), Akinori Kanai(Frontier Medical College), Katsutoshi Yoshizato(Hiroshima University), Fiona McPhee(Bristol-Myers Squibb (United States)), Yizhou Zhang(Nanjing University of Information Science and Technology), Min Gao(Central South University), Shoichi Takahashi(Hiroshima University), Hidenori Ochi(Hiroshima University), Chise Tateno-Mukaidani(Hiroshima University), Keiichi Kosaka(Hiroshima University), Toshiya Inaba(Hiroshima University)
Cited by 27
Related Papers
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
MXene hydrogels: fundamentals and applications
|Chemical Society Reviews|2020|712